AMTX-100-CF

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAMTX-100-CF
Drug Alias NameAMTX-100-CF
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTranscription factors modulators
TargetsTranscription factors
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmytrx Therapeutics IncVanderbilt University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesAmytrx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A